Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
2.
Femina ; 46(6): 381-385, 20181231. ilus
Article in Portuguese | LILACS | ID: biblio-1050694

ABSTRACT

Este protocolo visa apresentar os critérios e o algoritmo para o diagnóstico e o tratamento das disfunções sexuais femininas (DSFs), de acordo com os critérios da Classificação Internacional das Doenças (CID-10) utilizados pelo Sistema Único de Saúde (SUS) no Brasil. A classificação e os conceitos do DSM-V são utilizados para complementar a CID-10.(AU)


Subject(s)
Humans , Female , Sexuality , Sexual Dysfunctions, Psychological/classification , Sexual Dysfunctions, Psychological/diagnosis , Sexual Health , Medical History Taking/methods , Clinical Protocols , Risk Factors , Dyspareunia/diagnosis
8.
Rev. bras. ginecol. obstet ; 11(10): 202-5, out. 1989. ilus
Article in Portuguese | LILACS | ID: lil-95925

ABSTRACT

A case of sclerosinhg stomal tumor of the ovary in a 23 years old case is reported. She presented metrorrhagia and abdominal mass in the lower quadrants, measuring 12.5 x 16.7 x 9.0 cm (USG). clinically, there was anaovulation with result infertility, which was resistent to therapy with clomiphene citrate. The tumor was removed from the patient's left ovary. The cut surface showed a solid and edematous pattern. Histological examination revealed a mixture of fibromatous and lipoid cells separated by edematous or sclerosing stroma into pseudonodules. The tumor was benign and considered to arise from gonadal stroma of the ovary. Both menstrual disorders and problems of infertility were corrected by tumor's excision. Ultrastructural and immunohistochemistry studies, as well as clinical patterns have indicated in many cases, that the tumor is functionally active and from ovarian stromal origin. This specific tumor is worthwhile to present due to its rarity, its association with sterility and a difficulty in finding a definitive nomenclature. Two months after the surgery the patient was pregnant for the first time


Subject(s)
Humans , Female , Mesonephroma , Ovarian Neoplasms/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL